Cochrane Abstracts
Ziprasidone versus other atypical antipsychotics for schizophrenia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Ziprasidone Versus Other Atypical Antipsychotics for Schizophrenia." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434152/all/Ziprasidone_versus_other_atypical_antipsychotics_for_schizophrenia.
Ziprasidone versus other atypical antipsychotics for schizophrenia. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434152/all/Ziprasidone_versus_other_atypical_antipsychotics_for_schizophrenia. Accessed April 17, 2025.
Ziprasidone versus other atypical antipsychotics for schizophrenia. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434152/all/Ziprasidone_versus_other_atypical_antipsychotics_for_schizophrenia
Ziprasidone Versus Other Atypical Antipsychotics for Schizophrenia [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 April 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434152/all/Ziprasidone_versus_other_atypical_antipsychotics_for_schizophrenia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ziprasidone versus other atypical antipsychotics for schizophrenia
ID - 434152
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434152/all/Ziprasidone_versus_other_atypical_antipsychotics_for_schizophrenia
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
